Back to Agenda
Biomarkers for Drug Development: How Are We Dealing with the Challenges?
Session Chair(s)
Sue-Jane Wang, PhD, MA, MS
Mathematician Statistician
FDA, United States
Biomarkers have many potential applications in the development of drugs. These include potentially improving the predictability of treatment effect and/or major safety concerns, screening compounds for toxicity before entering clinical development, monitoring the development of toxicity, forecasting adverse events given wider exposure, and understanding the mechanism by which a drug works. In this session, knowledgeable statisticians and expert molecular scientists are invited to give their professional, research and practical perspectives. Topics range from biomarker development in preclinical studies along with its challenges of bridging biomarker utility from preclinical to clinical development, to statistical trends in trial durations and underlying drivers with a focus on biomarker in oncology, to challenges and utility of genomic biomarker development from an industry perspective. Additionally, examples from a few disease areas, such as Alzheimer’s and oncology, will be used to elucidate biomarker development and utility assessment.
Learning Objective : Describe biomarker developments for their potential in enhancing drug development; Describe global planning of clinical development programs from preclinical study through clinical development; Explain biomarker uses in medical product development.
Speaker(s)
From Animal to Man: Challenges of Biomarkers in Alzheimer's Research
Tom Jacobs, PhD
Janssen R&D, Belgium
Principal Statistician
Trends in Trial Durations and Underlying Drivers on Biomarkers in Oncology
Christine Blazynski, PhD
Citeline, Inc., United States
Chief Science Officer and Senior Vice President
Challenges to Oncology Biomarker Development and Clinical Utility: An Industry Perspective
William L. Trepicchio, PhD, MSc
Takeda Pharmaceuticals International, Inc., United States
Senior Director of Translational Medicine
Have an account?